Les Sulewski
Stock Analyst at Truist Financial
(4.19)
# 1,512
Out of 4,581 analysts
185
Total ratings
50%
Success rate
11.4%
Average return
Main Sectors:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRMD CorMedix | Maintained: Buy | n/a | $7.19 | - | 23 | May 15, 2026 | |
| COLL Collegium Pharmaceutical | Maintained: Buy | n/a | $36.29 | - | 20 | May 14, 2026 | |
| ANIP ANI Pharmaceuticals | Maintained: Hold | n/a | $81.78 | - | 25 | May 11, 2026 | |
| VTRS Viatris | Reiterated: Buy | $20 | $17.82 | +12.23% | 8 | May 8, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintained: Buy | $18 | $5.05 | +256.44% | 4 | May 7, 2026 | |
| PCRX Pacira BioSciences | Maintained: Buy | n/a | $26.40 | - | 24 | May 1, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Hold | n/a | $6.56 | - | 18 | May 1, 2026 | |
| TEVA Teva Pharmaceutical Industries | Rated: Buy | $42 → $45 | $34.71 | +29.65% | 11 | Apr 30, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintained: Buy | n/a | $19.10 | - | 21 | Apr 23, 2026 | |
| BTMD biote | Maintained: Buy | $5 → $4 | $2.04 | +96.08% | 19 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €22.00 | €26.20 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $105.92 | n/a | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23.88 → $19.67 | $17.38 | n/a | 5 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.51 | n/a | 5 | Jul 9, 2024 |
CorMedix
May 15, 2026
Maintained: Buy
Price Target: n/a
Current: $7.19
Upside: -
Collegium Pharmaceutical
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $36.29
Upside: -
ANI Pharmaceuticals
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $81.78
Upside: -
Viatris
May 8, 2026
Reiterated: Buy
Price Target: $20
Current: $17.82
Upside: +12.23%
Vanda Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: $18
Current: $5.05
Upside: +256.44%
Pacira BioSciences
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $26.40
Upside: -
Bausch Health Companies Inc.
May 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.56
Upside: -
Teva Pharmaceutical Industries
Apr 30, 2026
Rated: Buy
Price Target: $42 → $45
Current: $34.71
Upside: +29.65%
Amneal Pharmaceuticals
Apr 23, 2026
Maintained: Buy
Price Target: n/a
Current: $19.10
Upside: -
biote
Apr 16, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $2.04
Upside: +96.08%
May 27, 2025
Initiated Coverage: Buy
Price Target: €22.00
Current: €26.20
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $105.92
Upside: n/a
Jul 26, 2024
Maintained: Buy
Price Target: $23.88 → $19.67
Current: $17.38
Upside: n/a
Jul 9, 2024
Rated: Hold
Price Target: n/a
Current: $5.51
Upside: n/a